pipette
ESEspañol

Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury

Stèphane Gaudry, Marouane Boubaya, Guillaume Louis, Khalil Chaïbi, Étienne de Montmollin, Julien Bohé, Maxime Desgrouas, Clément Devautour, Adrien Joseph, Bruno Mégarbane, Christophe Camus, Pierre Bailly, Alexis Lambour, Romain Arrestier, Samir Jaber, Adrien Robine, Nicolas Chudeau, Guillaume Chevrel, Béatrice La Combe, Jonathan Nicolas, Laurent Argaud, Côme Bureau, Antoine Kimmoun, Noémie Zucman, Jean-Damien Ricard, Guillaume Thiéry, Stanislas Faguer, Mathieu Jozwiak, Nathan Ferrand, Benjamin Glenn Chousterman, Mehdi Marzouk, Julien Cadiet, Alain Combes, Arnaud Mari, Damien Contou, Roland Amathieu, Daniel Da Silva, Charlotte Salmon Gandonnière, Pierre-André Rodie-Talbere, Isabelle Durand‐Zaleski, Patrick Rossignol, Jean‐Pierre Quenot, Lucie Biard, Coralie Bloch, Didier Dreyfuss

Peer-reviewed journalReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
ConclusionsAmong critically ill patients with acute kidney injury who had indications for renal-replacement therapy, intermittent hemodialysis as the initial treatment approach was not shown to be noninferior to continuous renal-replacement therapy with respect to major adverse kidney events by day 90 and was associated with higher mortality.
Limitation the authors admit
ResultsThe trial was stopped early after sequential interim analyses showed a sustained signal of higher mortality with intermittent hemodialysis than with continuous renal-replacement therapy.

Appeared: Friday, October 16. New England Journal of Medicine. Peer-reviewed journal.

DOI: 10.1056/nejmoa2608397